Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases
- Substances:Nipocalimab
Italy- Participants:18–64 years · 65+ years
- Substances:Nipocalimab
- Sponsor:Janssen Cilag International
Rare diseases
Investigational molecules
Locations
Back to Italy2 831 clinical trials in Monza, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
ItalyStudy of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin
ItalyStudy on the Effectiveness and Safety of Tisagenlecleucel for Adults with Hard-to-Treat or Returning Follicular Lymphoma
ItalyComparison of Sotorasib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer Patients with KRAS p.
ItalyStudy of Valemetostat Tosylate for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
ItalyStudy Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
ItalyStudy of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors
Italy
ItalyStudy of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy
ItalyStudy on Long-term Safety and Effects of ARGX-117 for Adults with Multifocal Motor Neuropathy
ItalyStudy on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy
ItalyStudy on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lung cancer treatments and novel approaches for lymphoma management. Studies include targeted therapies and immunotherapy combinations.
Advanced investigations into personalized treatment approaches for various cancer types using targeted therapies and immunological interventions.
Research focusing on psoriatic arthritis and multiple sclerosis, evaluating novel biological treatments and their effectiveness in managing disease progression.
Comprehensive studies examining new therapeutic approaches for chronic autoimmune conditions.
Vaccine development studies targeting Herpes Zoster and Cytomegalovirus, focusing on prevention and immune response in different age groups.
Advanced clinical trials evaluating new vaccination approaches and therapeutic strategies.
Innovative research on heart failure prevention and pulmonary arterial hypertension, testing new therapeutic combinations and treatment approaches.
Investigation of novel therapeutic strategies for cardiovascular disease management and prevention.
Tell us about your condition – we search every trial in Europe and connect you with the right site.